Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
41.71
-0.89 (-2.09%)
Dec 5, 2025, 4:00 PM EST - Market closed
Maze Therapeutics Employees
Maze Therapeutics had 125 employees as of December 31, 2024.
Employees
125
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$811,664
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MAZE News
- 10 days ago - Maze Therapeutics, Inc. (MAZE) Presents at Jefferies London Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 4 weeks ago - Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - GlobeNewsWire
- 4 weeks ago - Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week - GlobeNewsWire
- 4 weeks ago - Maze Therapeutics to Participate in Four Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - San Francisco is making a comeback. So are these stocks from the City by the Bay - CNBC
- 2 months ago - Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewsWire
- 3 months ago - Maze Therapeutics, Inc. (MAZE) Discuses On MZE782 Phase 1 Healthy Volunteer Trial Results Call (Transcript) - Seeking Alpha
- 3 months ago - Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential - Benzinga